NeuroinflammationApril 2026
Beyond Neurons: The Microglial Revolution in Neurodegenerative Therapeutics
This month's Oxford Neuroinflammation Summit highlighted microglia as the converging therapeutic target across MS, Alzheimer's, and ALS. The MIF/CD74 signaling axis was featured as a central node driving chronic neuroinflammatory activation.
JFInnova Perspective
JFInnova's computational discovery independently identified the same axis — validating our target through convergent evidence from both academia and our AI pipeline.
References
1
MIF contribution to progressive brain diseases
Journal of Neuroinflammation · 2024
Microglia therapeutic targets 2026